[1]
W. Najantad, “Virological, Immunological, and Renal Outcomes after Fixed-Dose Tenofovir Disoproxil Fumarate–Lamivudine–Dolutegravir (TLD) among People Living with HIV at Phu Kradueng Hospital, Loei Province, Thailand: A Retrospective Cohort Study”, loei j., vol. 4, no. 3, pp. 41–57, Sep. 2026.